Self-assembly of tau fragments as a key pathologic event in tauopathies.

Neural Regen Res

Department of Biochemistry and Molecular Biology, Seoul National University College of Medicine, Seoul, Korea.

Published: December 2024


Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Article Abstract

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11168505PMC
http://dx.doi.org/10.4103/NRR.NRR-D-23-01720DOI Listing

Publication Analysis

Top Keywords

self-assembly tau
4
tau fragments
4
fragments key
4
key pathologic
4
pathologic event
4
event tauopathies
4
self-assembly
1
fragments
1
key
1
pathologic
1

Similar Publications

Lysine-Targeting Inhibitors of Amyloidogenic Protein Aggregation: A Promise for Neurodegenerative Proteinopathies.

JACS Au

August 2025

Department of Neurology, David Geffen School of Medicine, Brain Research Institute, and Molecular Biology Institute, University of California Los Angeles, Los Angeles, California 90095-7334, United States.

Inhibition of amyloidogenic-protein oligomerization and aggregation is a promising therapy-development strategy for proteinopathies, such as Alzheimer's and Parkinson's diseases, in which proteins self-associate into a variety of abnormal, toxic assemblies. Despite discovery of numerous compounds modulating the self-assembly process in vitro, few have reached advanced clinical trials, and none have translated into effective therapy to date. A potential reason is a lack of clear mechanistic understanding of the interaction between the inhibitors/modulators and the target metastable protein assemblies.

View Article and Find Full Text PDF

Biomolecular phase separation of microtubule-associated protein Tau and its role in the genesis of Brain Disorders.

Ageing Res Rev

August 2025

Biomolecular Self-Assembly Lab, Department of Biotechnology, School of Bioengineering, SRM Institute of Science and Technology, Kattankulathur, Tamil Nadu- 603203, India. Electronic address:

Microtubule-associated tau (MAP) is a crucial component for cellular cytoskeleton stability. However, upon hyperphosphorylation, these tau proteins detach from microtubules, leading to the genesis of clumpy fibrillar-rich β or paired helical filamental structures known as amyloids. Such deposits predispose a multitude of fatal disorders, including Alzheimer's Disease.

View Article and Find Full Text PDF

Disrupting Amyloid Filaments of Tau by Means of Electric Fields.

J Phys Chem B

August 2025

Department of Biochemistry, University of Zurich, Winterthurerstrasse 190, Zürich, ZH 8057, Switzerland.

The tau protein is a major component of neurofibrillary tangles, one of the hallmarks of Alzheimer's disease, which is the most common neurodegenerative disorder in the elderly. Experimental and computational studies have shed light on the fibrillar morphologies of tau and the kinetics of self-assembly, but little is known about the structural stability of the fibrils in the presence of external electric fields. We investigated the behavior of cross-β filaments of tau under the effect of an oscillating external electric field by means of multiple molecular dynamics simulations.

View Article and Find Full Text PDF

Intrastrand Peptide Staples That Promote β-Sheet Folding, Self-Assembly, and Amyloid Seeding.

J Am Chem Soc

August 2025

Department of Chemistry & Biochemistry, University of Notre Dame, Notre Dame, Indiana 46556, United States.

Side chain stapling of cysteine (Cys) residues offers convenient entry into constrained peptides with enhanced bioactivity and bioavailability. Despite its widespread application in the constraint of α-helical, PPII, and loop conformations, the stabilization of β-sheet folds via intrastrand side chain Cys stapling remains largely unexplored. Here, we demonstrate that →+2 stapling with -butenyl, butynyl, and -xylyl linkers significantly enhances the folded population of two distinct β-hairpin model peptides.

View Article and Find Full Text PDF

Polyserine-tau interactions modulate tau fibrillization.

J Biol Chem

July 2025

Department of Biochemistry, University of Colorado Boulder, Boulder, Colorado, USA; Howard Hughes Medical Institute, University of Colorado Boulder, Boulder, Colorado, USA. Electronic address:

Tau aggregates are the defining feature of multiple neurodegenerative diseases and contribute to the pathology of disease. However, the molecules affecting tau aggregation in cells are unclear. We previously determined that polyserine-rich domain containing proteins enrich in tau aggregates, form assemblies that can serve as sites of tau aggregation, and exacerbate tau aggregation in cells and mice.

View Article and Find Full Text PDF